EP3383371
PHARMACEUTICAL FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.12.2016EP published:
1.5.2024EP application number:
16871823.7
EPO information:
European Patent Register
Max expiry date:
8.12.2036
Title in English:
PHARMACEUTICAL FORMULATIONLanguage of the patent:
English
Timeline
Today
9.12.2016EP application
1.5.2024EP Publication
Owner
Name:
Avecho Biotechnology LimitedAddress:
Unit A8 2A Westall Road, Clayton, VIC 3168, AU
Inventor
Name:
EL-TAMIMY, MahmoudAddress:
Clayton, Victoria 3168, AU
Priority
Number:
2015905089Date:
9.12.2015Country:
AU
Number:
201662329166 PDate:
28.4.2016Country:
US
Classification
Categories:
A61K 9/107, A61K 47/22, A61K 47/26, A61K 47/10, A61P 25/20, A61K 31/05, A61K 31/355, A61P 23/00